FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Virginia Pellegrini

Research Profile

Procedures

Chemicals & Drugs

Objects

Alpha Particles

Living Beings

Disorders

Prostatic Neoplasms

Anatomy

Phenomena

Linear Energy Transfer

Concepts & Ideas

Antibody Affinity

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Ase M Ballangrud; Wei-Hong Yang; Stig Palm; Richard M Enmon; Paul E Borchardt; Virginia A Pellegrini; Michael R McDevitt; David A Scheinberg; George Sgouros
Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression.
Dangshe Ma; Michael R McDevitt; EC Barendswaard; L Lai; Michael J Curcio; Virginia A Pellegrini; Martin W Brechbiel; David A Scheinberg
Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.
Michael R McDevitt; Dangshe Ma; L T Lai; J Simon; Paul E Borchardt; R K Frank; K Wu; Virginia A Pellegrini; Michael J Curcio; Miederer Matthias; Neil H Bander; David A Scheinberg
Tumor therapy with targeted atomic nanogenerators.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Virginia Pellegrini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2004: Ase M Ballangrud; Wei-Hong Yang; Stig Palm; Richard M Enmon; Paul E Borchardt; Virginia A Pellegrini; Michael R McDevitt; David A Scheinberg; George Sgouros
Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(13):4489-97.
2002: Dangshe Ma; Michael R McDevitt; EC Barendswaard; L Lai; Michael J Curcio; Virginia A Pellegrini; Martin W Brechbiel; David A Scheinberg
Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.
Leukemia 2002;16(1):60-6.
2001: Michael R McDevitt; Dangshe Ma; L T Lai; J Simon; Paul E Borchardt; R K Frank; K Wu; Virginia A Pellegrini; Michael J Curcio; Miederer Matthias; Neil H Bander; David A Scheinberg
Tumor therapy with targeted atomic nanogenerators.
Science (New York, N.Y.) 2001;294(5546):1537-40.
2000: Michael R McDevitt; EC Barendswaard; Dangshe Ma; L Lai; Michael J Curcio; George Sgouros; Ase M Ballangrud; Wei-Hong Yang; Ronald D Finn; Virginia A Pellegrini; MW Geerlings; M Lee; Martin W Brechbiel; Neil H Bander; Carlos Cordon-Cardo; David A Scheinberg
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.
Cancer research 2000;60(21):6095-100.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.